Everence Capital Management’s GE HealthCare GEHC Stock Holding History

Everence Capital Management’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,516	Closed	-$1.52M	–	834
2025 Q4	$1.52M	Hold	18,516	–	–	0.09%	180
2025 Q3	$1.39M	Buy	18,516 +8,606	+87%	+$642K	0.08%	186
2025 Q2	$734K	Sell	9,910 -2,980	-23%	-$207K	0.05%	281
2025 Q1	$1.04M	Sell	12,890 -5,980	-32%	-$514K	0.07%	224
2024 Q4	$1.48M	Buy	18,870 +10,220	+118%	+$869K	0.1%	171
2024 Q3	$812K	Hold	8,650	–	–	0.05%	284
2024 Q2	$659	Hold	8,650	–	–	0.05%	309
2024 Q1	$786	Hold	8,650	–	–	0.05%	278
2023 Q4	$669K	Hold	8,650	–	–	0.05%	315
2023 Q3	$589	Buy	8,650 +4,410	+104%	+$321K	0.05%	333
2023 Q2	$337K	Hold	4,240	–	–	0.03%	484
2023 Q1	$348	Buy	+4,240	New	+$303K	0.03%	481

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Everence Capital Management's GEHC Position: Q1 2026 in Review

Everence Capital Management sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 18,516 shares — an estimated $1.52M sold.

Everence Capital Management first reported a position in GEHC in Q1 2023 and held it in 12 quarters. The position peaked at $1.52M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Everence Capital Management reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 18,516 GE HealthCare shares in Q1 2026, an estimated $1.52M.
Everence Capital Management first reported a position in GE HealthCare in Q1 2023 and held it in 12 quarters.
Everence Capital Management's GE HealthCare position peaked at $1.52M in Q4 2025.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.